Curtis Gale Oltmans - Apr 26, 2023 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Signature
/s/ Curt Oltmans
Stock symbol
FULC
Transactions as of
Apr 26, 2023
Transactions value $
$0
Form type
4
Date filed
4/28/2023, 04:16 PM
Previous filing
Feb 13, 2023
Next filing
Jul 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +128K $0.00 128K Apr 26, 2023 Common Stock 128K $2.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted to the reporting person under the Fulcrum 2019 Stock Incentive Plan (the "Plan") as part of an executive retention program and will vest 25% on the first anniversary of the grant date. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years, such that the options will be vested in full on the four-year anniversary of the grant date, and subject to the reporting person's continuing to be an "Eligible Participant" (as defined in the Plan) on each such vesting date.